Telomir Pharmaceuticals, Inc. Common Stock
TELO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $43 | $38 | $96 | $122 |
| - Cash | $7 | $1 | $0 | $1 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $36 | $37 | $96 | $121 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$1 | -$5 | -$2 | -$3 |
| % Margin | – | – | – | – |
| Net Income | -$1 | -$5 | -$2 | -$3 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.034 | -0.17 | -0.073 | -0.098 |
| % Growth | 80% | -132.2% | 25.3% | – |
| Operating Cash Flow | -$1 | -$1 | -$1 | -$1 |
| Capital Expenditures | $0 | $0 | $0 | -$0 |
| Free Cash Flow | -$1 | -$1 | -$1 | -$1 |